XBIT - XBiotech Inc.
2.34
0.010 0.427%
Share volume: 25,217
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.33
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-12-2024 | 11-13-2024 | 03-18-2025 | 05-14-2025 | 08-13-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 227.858 M | 215.555 M | 209.851 M | 199.093 M | 181.864 M | 178.682 M | 172.424 M | |
| Current Assets | 203.056 M | 190.639 M | 185.034 M | 174.567 M | 157.685 M | 154.889 M | 148.951 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 201.039 M | 188.530 M | 183.118 M | 172.677 M | 155.897 M | 152.938 M | 147.367 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 24.802 M | 24.916 M | 24.817 M | 24.526 M | 24.179 M | 23.793 M | 23.473 M | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 227.858 M | 215.555 M | 209.851 M | 199.093 M | 181.864 M | 178.682 M | 172.424 M | |
| Total liabilities | 18.578 M | 18.854 M | 17.736 M | 16.825 M | 7.151 M | 5.618 M | 5.344 M | |
| Total current liabilities | 16.884 M | 17.135 M | 15.992 M | 15.105 M | 5.410 M | 3.857 M | 3.565 M | |
| Accounts Payable | 2.607 M | 1.704 M | 1.506 M | 2.223 M | 1.100 M | 1.431 M | 1.043 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 209.280 M | 196.701 M | 192.115 M | 182.268 M | 174.713 M | 173.064 M | 167.080 M | |
| Common stock | 271.588 M | 272.015 M | 272.444 M | 273.105 M | 276.434 M | 276.541 M | 276.565 M | |
| Retained earnings | -62.308 M | -75.314 M | -80.329 M | -90.837 M | -101.721 M | -103.477 M | -109.485 M |